News|Articles|January 31, 2024

Recap: Clinician Wellness 2024

Here’s a look back at selections from our January content series on clinician wellness.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Poll: Has the Shortage of IV Ativan Impacted Your Practice?

ByPsychiatric Times Editors

November 5th 2025

Presenting Our November Theme: Best Practices

ByLeah Kuntz

November 3rd 2025

Burnout and Subfertility in Female Physicians: Examining the Bidirectional Relationship and Emphasizing the Need for Change

BySarah Hakam, BS,Nidal Moukaddam, MD, PhD

July 24th 2025

Spare Me the Bouquets: The Growing Crisis of Being a Doctor in India

ByHarneet Kaur, MD

July 1st 2025

Preparing for the Future: The Psychiatric Workforce

ByMichael Asbach, DMSc, PA-C, Psych-CAQ,Mitchell Anderson, PA-S,Citlalli Marin, PA-S

June 11th 2025

Latest CME

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Recap: Clinician Wellness 2024

Newsletter

Related Content

Poll: Has the Shortage of IV Ativan Impacted Your Practice?

Presenting Our November Theme: Best Practices

Burnout and Subfertility in Female Physicians: Examining the Bidirectional Relationship and Emphasizing the Need for Change

Spare Me the Bouquets: The Growing Crisis of Being a Doctor in India

Preparing for the Future: The Psychiatric Workforce

Latest CME

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

ADHD: Correcting Careless Myths

Toward a Spiritual Psychiatry Subspecialty

Tonmya Available Commercially for Treatment of Fibromyalgia

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

Making Chatbots Safe For Suicidal Patients